Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Wise went public at a peak euphoria valuation near 390x earnings. Despite fundamentals compounding rapidly, the stock has been flat as the valuation multiple compressed to a more sustainable level. This illustrates the risk of overpaying, even for a great business.

Related Insights

Cisco's stock took 25 years to reclaim its year-2000 peak, despite the underlying business growing significantly. This serves as a stark reminder that even a successful, growing company can deliver zero returns for decades if an investor buys in at an extremely high, bubble-era valuation.

When a company is growing 10x or 50x year-over-year, obsessing over the entry multiple is a mistake. An initially 'insane' valuation can look cheap in retrospect. The primary focus should be on determining if the company is on an exponential curve; price is the least important factor in that equation.

At the seed stage, if you're right about a truly exceptional company, the entry valuation hardly matters. Gokul cites a 200x return on an expensive seed deal. However, by Series B, a high price can crush your multiple, even if the company continues to perform well.

The paper wealth generated on IPO day is a misleading metric due to lockup periods and market volatility. A more accurate mental model for an investor's actual return is the company's market capitalization 18 months after the public offering. This timeframe provides a truer 'locked in value' after initial hype and selling pressure subsides.

An investor passed on a fund that paid 30-40x revenue for startups, believing quality alone justifies price. Three years later, that fund and its predecessors are underwater. This illustrates that even for great companies, undisciplined entry valuations and the assumption of multiple expansion can lead to poor returns.

Public market investors systematically underestimate sustained high growth (e.g., 60%+), defaulting to models that assume rapid deceleration. This creates an opportunity for private investors with longer time horizons to more accurately value these companies.

Private market valuations are benchmarked against public multiples. Currently, public SaaS firms with 30% growth trade at 15-20x revenue, twice the historical average. If this 'bedrock price' reverts to its 7-8x mean, it will trigger a cascade of valuation drops across the private markets.

While media often highlights the costs of being public, the valuation multiple is an overlooked benefit. A consistently growing small business can command a 20x P/E ratio, far exceeding the typical 3x cash flow multiple offered in a private equity buyout.

Public market investors often build financial models that automatically taper down high growth rates (e.g., 60% to 50% to 40%). This systemic underestimation creates an arbitrage opportunity for private investors who can better value sustained hyper-growth over a longer time horizon.

Zoom's stock has barely moved since its IPO, despite a 1700% increase in free cash flow. This serves as a stark reminder that even phenomenal business growth cannot generate investor returns if the initial purchase price was astronomically high. Valuation truly matters.